Multinationals in China Must Operate According to Law

摘要

A few months ago,the Glaxo SmithKline(GSK)China bribery allegations have sent shockwaves through the country’s pharmaceutical sector,stirring uproar both in China and overseas.On July 11,2013,the Ministry of Public Security in China officially opened investigations into the suspected economic crimes of some of GSK’s senior executives.The company was accused of bribing,in cash or other benefits,gov-